Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 25 | 2022 | 3976 | 4.540 |
Why?
|
Quality Improvement | 6 | 2020 | 851 | 2.220 |
Why?
|
Operating Rooms | 2 | 2019 | 122 | 1.290 |
Why?
|
Program Evaluation | 2 | 2020 | 597 | 1.220 |
Why?
|
Free Tissue Flaps | 3 | 2020 | 372 | 1.140 |
Why?
|
Specialties, Surgical | 2 | 2019 | 137 | 1.080 |
Why?
|
Neoadjuvant Therapy | 5 | 2021 | 4975 | 0.990 |
Why?
|
Mouth Neoplasms | 3 | 2019 | 713 | 0.930 |
Why?
|
Postoperative Complications | 8 | 2022 | 5542 | 0.770 |
Why?
|
Quality Indicators, Health Care | 3 | 2015 | 348 | 0.770 |
Why?
|
Patient Readmission | 4 | 2019 | 548 | 0.730 |
Why?
|
Intubation, Intratracheal | 2 | 2019 | 445 | 0.730 |
Why?
|
Laryngoscopy | 3 | 2019 | 183 | 0.720 |
Why?
|
Language Therapy | 1 | 2019 | 5 | 0.710 |
Why?
|
Speech Therapy | 1 | 2019 | 12 | 0.710 |
Why?
|
Critical Pathways | 1 | 2020 | 149 | 0.690 |
Why?
|
Surgical Flaps | 3 | 2020 | 927 | 0.690 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 95 | 0.670 |
Why?
|
Guideline Adherence | 2 | 2015 | 636 | 0.670 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 585 | 0.670 |
Why?
|
Pneumonia, Aspiration | 1 | 2018 | 41 | 0.660 |
Why?
|
Watchful Waiting | 1 | 2021 | 289 | 0.660 |
Why?
|
Intraoperative Complications | 1 | 2020 | 301 | 0.630 |
Why?
|
Tonsillar Neoplasms | 2 | 2015 | 80 | 0.620 |
Why?
|
Airway Management | 1 | 2019 | 102 | 0.620 |
Why?
|
Tongue | 1 | 2017 | 77 | 0.600 |
Why?
|
Poroma | 1 | 2016 | 9 | 0.580 |
Why?
|
Recovery of Function | 1 | 2020 | 703 | 0.580 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2018 | 5437 | 0.570 |
Why?
|
Length of Stay | 6 | 2022 | 1900 | 0.550 |
Why?
|
Patient Preference | 1 | 2018 | 218 | 0.540 |
Why?
|
Sweat Gland Neoplasms | 1 | 2016 | 71 | 0.540 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 246 | 0.520 |
Why?
|
Health Personnel | 1 | 2021 | 625 | 0.520 |
Why?
|
Fees, Medical | 1 | 2014 | 11 | 0.520 |
Why?
|
Feedback, Psychological | 1 | 2015 | 18 | 0.520 |
Why?
|
Academic Medical Centers | 2 | 2016 | 672 | 0.500 |
Why?
|
Deglutition Disorders | 1 | 2018 | 447 | 0.500 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 126 | 0.480 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 573 | 0.480 |
Why?
|
Medical Audit | 1 | 2015 | 188 | 0.480 |
Why?
|
Cancer Survivors | 1 | 2021 | 650 | 0.470 |
Why?
|
Health Services Accessibility | 1 | 2019 | 761 | 0.450 |
Why?
|
Aged | 22 | 2022 | 70117 | 0.440 |
Why?
|
Healthcare Disparities | 1 | 2018 | 598 | 0.430 |
Why?
|
Facial Neoplasms | 1 | 2013 | 84 | 0.420 |
Why?
|
Retrospective Studies | 17 | 2022 | 37905 | 0.420 |
Why?
|
Humans | 47 | 2022 | 261506 | 0.420 |
Why?
|
SEER Program | 3 | 2021 | 1000 | 0.410 |
Why?
|
Alveolar Process | 1 | 2010 | 10 | 0.380 |
Why?
|
Jaw Diseases | 1 | 2010 | 21 | 0.380 |
Why?
|
Granuloma, Plasma Cell | 1 | 2010 | 38 | 0.370 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2019 | 1105 | 0.370 |
Why?
|
Skin Neoplasms | 3 | 2021 | 4654 | 0.370 |
Why?
|
Health Policy | 1 | 2013 | 291 | 0.370 |
Why?
|
Video-Assisted Surgery | 1 | 2010 | 28 | 0.360 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 671 | 0.360 |
Why?
|
Aged, 80 and over | 12 | 2020 | 29902 | 0.360 |
Why?
|
Reoperation | 3 | 2020 | 1382 | 0.350 |
Why?
|
Male | 27 | 2022 | 123000 | 0.350 |
Why?
|
Surgical Procedures, Operative | 3 | 2020 | 383 | 0.340 |
Why?
|
Pneumocephalus | 1 | 2008 | 7 | 0.340 |
Why?
|
Practice Guidelines as Topic | 3 | 2015 | 2403 | 0.330 |
Why?
|
Tracheotomy | 1 | 2008 | 27 | 0.330 |
Why?
|
Pharyngeal Diseases | 2 | 2016 | 53 | 0.330 |
Why?
|
Hirudins | 1 | 2008 | 65 | 0.320 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2008 | 60 | 0.310 |
Why?
|
Surgeons | 1 | 2015 | 519 | 0.310 |
Why?
|
Laryngectomy | 2 | 2020 | 242 | 0.300 |
Why?
|
Middle Aged | 20 | 2021 | 86204 | 0.300 |
Why?
|
Malacoplakia | 1 | 2006 | 4 | 0.300 |
Why?
|
Axilla | 1 | 2010 | 902 | 0.290 |
Why?
|
Tongue Diseases | 1 | 2006 | 17 | 0.290 |
Why?
|
Quinazolines | 1 | 2012 | 923 | 0.290 |
Why?
|
Thyroidectomy | 1 | 2010 | 486 | 0.290 |
Why?
|
Surgical Wound Infection | 4 | 2020 | 450 | 0.290 |
Why?
|
Skull | 1 | 2008 | 231 | 0.290 |
Why?
|
Robotics | 2 | 2010 | 359 | 0.290 |
Why?
|
Female | 24 | 2021 | 141928 | 0.280 |
Why?
|
Feasibility Studies | 3 | 2020 | 2292 | 0.280 |
Why?
|
Gastrostomy | 2 | 2020 | 180 | 0.280 |
Why?
|
Perioperative Care | 2 | 2020 | 451 | 0.280 |
Why?
|
Face | 1 | 2008 | 273 | 0.280 |
Why?
|
Medical Oncology | 2 | 2022 | 1423 | 0.270 |
Why?
|
Thyroid Neoplasms | 3 | 2016 | 1866 | 0.270 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 584 | 0.270 |
Why?
|
Microsurgery | 1 | 2008 | 244 | 0.270 |
Why?
|
Biopsy, Fine-Needle | 1 | 2009 | 690 | 0.270 |
Why?
|
Osteosarcoma | 1 | 2013 | 929 | 0.270 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 324 | 0.270 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2008 | 285 | 0.270 |
Why?
|
Medicare | 2 | 2021 | 860 | 0.260 |
Why?
|
Lymphoproliferative Disorders | 1 | 2007 | 366 | 0.240 |
Why?
|
United States | 6 | 2021 | 15433 | 0.230 |
Why?
|
Carcinoma | 1 | 2014 | 2578 | 0.220 |
Why?
|
Riots | 1 | 2022 | 6 | 0.220 |
Why?
|
Young Adult | 6 | 2020 | 21445 | 0.210 |
Why?
|
Disease-Free Survival | 3 | 2021 | 10001 | 0.210 |
Why?
|
Thrombosis | 1 | 2008 | 781 | 0.200 |
Why?
|
Survival Analysis | 3 | 2020 | 9180 | 0.200 |
Why?
|
Risk Factors | 6 | 2022 | 17523 | 0.190 |
Why?
|
Osteoradionecrosis | 1 | 2022 | 123 | 0.190 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 1371 | 0.190 |
Why?
|
Oncology Service, Hospital | 1 | 2020 | 48 | 0.190 |
Why?
|
Adult | 12 | 2020 | 77950 | 0.190 |
Why?
|
Risk Adjustment | 1 | 2020 | 83 | 0.180 |
Why?
|
Fistula | 1 | 2020 | 76 | 0.180 |
Why?
|
Gastric Bypass | 1 | 2020 | 81 | 0.180 |
Why?
|
Bias | 1 | 2020 | 205 | 0.180 |
Why?
|
Analgesia | 1 | 2020 | 94 | 0.180 |
Why?
|
Morbidity | 1 | 2020 | 397 | 0.170 |
Why?
|
Treatment Outcome | 7 | 2022 | 32848 | 0.170 |
Why?
|
Pharyngeal Neoplasms | 2 | 2016 | 133 | 0.170 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 280 | 0.160 |
Why?
|
Mouth | 1 | 2019 | 122 | 0.160 |
Why?
|
Pain, Postoperative | 2 | 2020 | 610 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2015 | 621 | 0.160 |
Why?
|
Cohort Studies | 3 | 2019 | 9244 | 0.160 |
Why?
|
Tracheostomy | 1 | 2020 | 243 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 310 | 0.150 |
Why?
|
Patient Reported Outcome Measures | 2 | 2020 | 799 | 0.150 |
Why?
|
Time Factors | 3 | 2020 | 12926 | 0.150 |
Why?
|
Biopsy | 2 | 2016 | 3443 | 0.150 |
Why?
|
Respiration, Artificial | 1 | 2020 | 577 | 0.150 |
Why?
|
Skull Base | 1 | 2017 | 199 | 0.140 |
Why?
|
Patient Compliance | 1 | 2020 | 667 | 0.140 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 980 | 0.140 |
Why?
|
Laryngeal Neoplasms | 2 | 2016 | 518 | 0.130 |
Why?
|
Patient Education as Topic | 1 | 2020 | 748 | 0.130 |
Why?
|
Prognosis | 3 | 2021 | 21713 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 4744 | 0.130 |
Why?
|
Disease Models, Animal | 1 | 2008 | 7222 | 0.130 |
Why?
|
Selection Bias | 1 | 2015 | 50 | 0.130 |
Why?
|
Patient Care Team | 1 | 2020 | 795 | 0.130 |
Why?
|
Head | 1 | 2016 | 249 | 0.130 |
Why?
|
Blood Component Transfusion | 1 | 2015 | 89 | 0.130 |
Why?
|
Memory Disorders | 1 | 2017 | 295 | 0.120 |
Why?
|
Pain Management | 1 | 2020 | 668 | 0.120 |
Why?
|
Hospitals, University | 1 | 2015 | 209 | 0.120 |
Why?
|
Observational Studies as Topic | 1 | 2015 | 140 | 0.120 |
Why?
|
Pneumonia | 1 | 2020 | 751 | 0.120 |
Why?
|
Neoplasm Staging | 4 | 2021 | 13658 | 0.120 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 4314 | 0.120 |
Why?
|
Neck Dissection | 1 | 2014 | 290 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 2017 | 314 | 0.120 |
Why?
|
Tonsillectomy | 1 | 2014 | 102 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8865 | 0.120 |
Why?
|
Program Development | 1 | 2015 | 261 | 0.110 |
Why?
|
Incidence | 3 | 2015 | 5673 | 0.110 |
Why?
|
Forehead | 1 | 2013 | 27 | 0.110 |
Why?
|
Logistic Models | 1 | 2020 | 3441 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 10035 | 0.110 |
Why?
|
Follow-Up Studies | 4 | 2019 | 14889 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 14289 | 0.110 |
Why?
|
Neoplasm Grading | 1 | 2017 | 1742 | 0.110 |
Why?
|
Physicians | 1 | 2021 | 882 | 0.110 |
Why?
|
Cognitive Dysfunction | 1 | 2017 | 333 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 4 | 2016 | 7551 | 0.100 |
Why?
|
CD40 Antigens | 1 | 2012 | 104 | 0.100 |
Why?
|
Databases, Factual | 1 | 2018 | 2218 | 0.100 |
Why?
|
Prevalence | 1 | 2018 | 3260 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6207 | 0.090 |
Why?
|
Frontal Sinus | 1 | 2010 | 14 | 0.090 |
Why?
|
Mucocele | 1 | 2010 | 22 | 0.090 |
Why?
|
Maxilla | 1 | 2010 | 84 | 0.090 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 884 | 0.090 |
Why?
|
Insufflation | 1 | 2010 | 25 | 0.090 |
Why?
|
Endoscopy | 2 | 2010 | 479 | 0.090 |
Why?
|
Survival Rate | 3 | 2014 | 12221 | 0.090 |
Why?
|
Adolescent | 5 | 2017 | 31252 | 0.090 |
Why?
|
Adoptive Transfer | 1 | 2012 | 446 | 0.090 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 368 | 0.090 |
Why?
|
Dissection | 1 | 2010 | 156 | 0.090 |
Why?
|
Cadaver | 1 | 2010 | 237 | 0.090 |
Why?
|
Chemoradiotherapy | 1 | 2018 | 1946 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3981 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2015 | 1274 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2009 | 355 | 0.080 |
Why?
|
Carbon Dioxide | 1 | 2010 | 313 | 0.080 |
Why?
|
Thyroid Nodule | 1 | 2009 | 92 | 0.080 |
Why?
|
Induction Chemotherapy | 1 | 2012 | 669 | 0.080 |
Why?
|
Texas | 2 | 2020 | 6311 | 0.080 |
Why?
|
Immunotherapy | 1 | 2021 | 3341 | 0.080 |
Why?
|
Microcirculation | 1 | 2008 | 200 | 0.080 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2015 | 2104 | 0.070 |
Why?
|
Publishing | 1 | 2009 | 220 | 0.070 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2010 | 500 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2008 | 371 | 0.070 |
Why?
|
Equipment Design | 1 | 2010 | 1204 | 0.070 |
Why?
|
Risk Assessment | 1 | 2018 | 6869 | 0.070 |
Why?
|
Incidental Findings | 1 | 2007 | 272 | 0.060 |
Why?
|
Neoplasms | 2 | 2022 | 15193 | 0.060 |
Why?
|
Child | 4 | 2013 | 29154 | 0.060 |
Why?
|
Graft Survival | 1 | 2008 | 1062 | 0.060 |
Why?
|
Prospective Studies | 1 | 2019 | 12873 | 0.060 |
Why?
|
Neck | 1 | 2007 | 383 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2011 | 860 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 2063 | 0.060 |
Why?
|
ErbB Receptors | 1 | 2012 | 2295 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2008 | 2927 | 0.050 |
Why?
|
Mandibular Osteotomy | 1 | 2022 | 33 | 0.050 |
Why?
|
Preoperative Care | 1 | 2008 | 1529 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 4971 | 0.050 |
Why?
|
Mandible | 1 | 2022 | 188 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 4892 | 0.050 |
Why?
|
Smoking | 2 | 2022 | 2440 | 0.050 |
Why?
|
Drainage | 1 | 2022 | 416 | 0.040 |
Why?
|
Rats | 1 | 2008 | 6086 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2012 | 3869 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 4367 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2020 | 467 | 0.040 |
Why?
|
Hypoalbuminemia | 1 | 2016 | 46 | 0.040 |
Why?
|
Survivorship | 1 | 2017 | 109 | 0.040 |
Why?
|
Cutaneous Fistula | 1 | 2016 | 46 | 0.040 |
Why?
|
Sex Factors | 1 | 2022 | 2139 | 0.040 |
Why?
|
Pain Measurement | 1 | 2020 | 953 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2017 | 224 | 0.030 |
Why?
|
Hospitals, High-Volume | 1 | 2016 | 77 | 0.030 |
Why?
|
Surveys and Questionnaires | 2 | 2021 | 5687 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 129 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2017 | 4320 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2007 | 2967 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 344 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 700 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2017 | 497 | 0.030 |
Why?
|
Hematoma | 1 | 2016 | 160 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2021 | 915 | 0.030 |
Why?
|
Central Nervous System | 1 | 2017 | 436 | 0.030 |
Why?
|
Pilot Projects | 1 | 2021 | 2803 | 0.030 |
Why?
|
Body Mass Index | 1 | 2022 | 2203 | 0.030 |
Why?
|
Xerostomia | 1 | 2015 | 190 | 0.030 |
Why?
|
Patient Outcome Assessment | 1 | 2015 | 245 | 0.030 |
Why?
|
Symptom Assessment | 1 | 2015 | 267 | 0.030 |
Why?
|
Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
B7-2 Antigen | 1 | 2012 | 55 | 0.030 |
Why?
|
gp100 Melanoma Antigen | 1 | 2012 | 88 | 0.030 |
Why?
|
B7-1 Antigen | 1 | 2012 | 88 | 0.030 |
Why?
|
Odds Ratio | 1 | 2016 | 2316 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2012 | 272 | 0.020 |
Why?
|
Cognition | 1 | 2017 | 968 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2020 | 6100 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 7702 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2017 | 1411 | 0.020 |
Why?
|
Survivors | 1 | 2015 | 1031 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1824 | 0.020 |
Why?
|
Obesity | 1 | 2022 | 2884 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2016 | 4298 | 0.020 |
Why?
|
Fatigue | 1 | 2015 | 1239 | 0.020 |
Why?
|
Mass Screening | 1 | 2017 | 1509 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2010 | 209 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2012 | 842 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 943 | 0.020 |
Why?
|
Animals | 2 | 2012 | 59536 | 0.020 |
Why?
|
Research Design | 1 | 2013 | 1544 | 0.020 |
Why?
|
Cell Line | 1 | 2012 | 5114 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2012 | 5710 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 6942 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 4532 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 16273 | 0.010 |
Why?
|
Mice | 1 | 2012 | 34495 | 0.010 |
Why?
|